Loading…

Boston Scientific has closed its acquisition of Silk Road Medical for $27.50 per share, with an enterprise value of $1.18 billion, adding stroke prevention devices to its portfolio.
“Boston Scientific said Tuesday that it has closed its acquisition of Silk Road Medical, completing the deal three months after announcing the proposal.”medtechdive.com
Summarized from public sources; check the original articles before acting on it.